|
2024
|
Invention
|
Fibroblast activation markers and tgfbi in therapy. The present invention relates to a method for... |
|
2021
|
Invention
|
Dual amylin and calcitonin receptor agonists and uses thereof. The present disclosure related to ... |
|
|
Invention
|
Oxyntomodulin mimetics. Disclosed herein are oxyntomodulin mimetics, and their use as medicaments... |
|
2019
|
Invention
|
Acylated calcitonin mimetics.
Disclosed herein are calcitonin mimetics that are acylated at a ly... |
|
|
Invention
|
Calcitonin analogues for treating diseases and disorders.
Calcitonin analogues as a medicament f... |
|
|
Invention
|
Calcitonin mimetics for treating diseases and disorders.
Calcitonin mimetic peptides having an a... |
|
2018
|
Invention
|
Dual amylin and calcitonin receptor agonists for treating diseases and disorders. The present inv... |
|
|
Invention
|
Calcitonin mimetics for treating diseases and disorders.
The present invention relates to humani... |
|
|
Invention
|
Calcitonin mimetics for treating diseases and disorders. The present invention relates to humanis... |
|
2017
|
Invention
|
Peptide analogs for treating diseases and disorders. Provided herein are methods for the treatmen... |
|
2016
|
Invention
|
Peptide analogs for treating diseases and disorders. Provided herein are peptides, that in combin... |
|
|
G/S
|
Pharmaceutical drugs. |
|
|
Invention
|
Methods of treating medical conditions using peptides. The present invention provides peptides an... |
|
|
Invention
|
Calcitonin analogues for treating diseases and disorders. Calcitonin analogues as a medicament fo... |
|
2014
|
Invention
|
Calcitonin mimetics for treating diseases and disorders. Calcitonin mimetic peptides having an am... |
|
2012
|
Invention
|
Peptide analogs for treating diseases and disorders. A peptide having a sequence selected from SE... |
|
2011
|
Invention
|
Treatment for obesity. The present invention provides peptides and pharmaceutical compositions th... |
|
|
Invention
|
Treatment of cartilage resorption.
Excessive articular cartilage degradation is treated or preve... |
|
2010
|
Invention
|
Treatment of diabetes and metabolic syndrome.
Enterally administered calcitonin family members o... |
